Golden Throat Holdings Group Company Limited (HKG:6896)
1.940
-0.010 (-0.51%)
Sep 18, 2026, 4:08 PM HKT
HKG:6896 Revenue
Golden Throat Holdings Group Company had revenue of 280.13M CNY in the half year ending June 30, 2026, a decrease of -46.59%. This brings the company's revenue in the last twelve months to 904.16M, down -7.71% year-over-year. In the year 2025, Golden Throat Holdings Group Company had annual revenue of 943.26M, down -20.40%.
Revenue (ttm)
904.16M CNY
Revenue Growth
-7.71%
P/S Ratio
1.37
Revenue / Employee
1.10M CNY
Employees
824
Market Cap
1.43B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 943.26M | -241.75M | -20.40% |
| Dec 31, 2024 | 1.19B | 223.63M | 23.26% |
| Dec 31, 2023 | 961.38M | -30.64M | -3.09% |
| Dec 31, 2022 | 992.01M | 171.47M | 20.90% |
| Dec 31, 2021 | 820.54M | 173.60M | 26.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| CPBIO Holding Company | 3.32B |
| Edding Genor Group Holdings | 2.57B |
| Essex Bio-Technology | 1.72B |
| Jacobson Pharma Corporation | 1.57B |
| Lee's Pharmaceutical Holdings | 1.54B |
| Dawnrays Pharmaceutical (Holdings) | 1.32B |
| Jilin Province Huinan Changlong Bio-pharmacy Company | 1.04B |
| JBM (Healthcare) | 834.63M |